Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1966 May;19(3):250–256. doi: 10.1136/jcp.19.3.250

Alpha-hydroxybutyrate dehydrogenase activity in sex-linked muscular dystrophy

H A Johnston 1,2,3,1, J H Wilkinson 1,2,3,2, Wendy A Withycombe 1,2,3,3, S Raymond 1,2,3,2
PMCID: PMC473248  PMID: 5937610

Abstract

In two families with severe sex-linked muscular dystrophy, high levels of α-hydroxybutyrate dehydrogenase (HBD), lactate dehydrogenase (LD), aspartate transaminase (AspT), aldolase, and creatine phosphokinase (CPK) were found in the sera of three young affected males. In both families the mother had a raised level of HBD activity. Four sisters of the three affected boys had raised serum enzyme levels, and they are regarded as presumptive carriers of the disease. Biopsy specimens of dystrophic muscle had LD and HBD contents which were significantly lower than those of control specimens, while the HBD/LD ratios were markedly greater. Muscle from two unaffected members of the same family also exhibited high ratios, indicating the presence of the electrophoretically fast LD isoenzymes, and this was confirmed by acrylamide-gel electrophoresis.

Full text

PDF
255

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AEBI U., RICHTERICH R., COLOMBO J. P., ROSSI E. Progressive muscular dystrophy. II. Biochemical identification of the carrier state in the recessive sex-linked juvennile (Duchenne) type by serum creatine-phosphokinase determinations. Epilepsia. 1961;1:61–74. [PubMed] [Google Scholar]
  2. BRODY I. A. THE SIGNIFICANCE OF LACTATE DEHYDROGENASE ISOZYMES IN ABNORMAL HUMAN SKELETAL MUSCLE. Neurology. 1964 Dec;14:1091–1100. doi: 10.1212/wnl.14.12.1091. [DOI] [PubMed] [Google Scholar]
  3. CLAYTON B. E., WILSON K. M., CARTER C. O. Aldolase activity in the plasma or serum of normal children and families with muscular dystrophy. Arch Dis Child. 1963 Jun;38:208–214. doi: 10.1136/adc.38.199.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cahn R. D., Zwilling E., Kaplan N. O., Levine L. Nature and Development of Lactic Dehydrogenases: The two major types of this enzyme form molecular hybrids which change in makeup during development. Science. 1962 Jun 15;136(3520):962–969. doi: 10.1126/science.136.3520.962. [DOI] [PubMed] [Google Scholar]
  5. DAWSON D. M., GOODFRIEND T. L., KAPLAN N. O. LACTIC DEHYDROGENASES: FUNCTIONS OF THE TWO TYPES RATES OF SYNTHESIS OF THE TWO MAJOR FORMS CAN BE CORRELATED WITH METABOLIC DIFFERENTIATION. Science. 1964 Feb 28;143(3609):929–933. doi: 10.1126/science.143.3609.929. [DOI] [PubMed] [Google Scholar]
  6. DREYFUS J. C., DEMOS J., SCHAPIRA F., SCHAPIRA G. [Muscle lactic dehydrogenase in myopathy: apparent persistence of the fetal type]. C R Hebd Seances Acad Sci. 1962 Jun 18;254:4384–4386. [PubMed] [Google Scholar]
  7. DREYFUS J. C., SCHAPIRA G., SCHAPIRA F. Serum enzymes in the physiopathology of muscle. Ann N Y Acad Sci. 1958 Oct 13;75(1):235–249. doi: 10.1111/j.1749-6632.1958.tb36870.x. [DOI] [PubMed] [Google Scholar]
  8. DREYFUS J. C., SCHAPIRA G. [Technique for the determination of creatine phosphokinase in blood]. Rev Fr Etud Clin Biol. 1961 Aug-Sep;6:700–703. [PubMed] [Google Scholar]
  9. ELLIOTT B. A., WILKINSON J. H. Serum "alpha-hydroxybutyric dehydrogenase" in myocardial infarction and in liver disease. Lancet. 1961 Apr 1;1(7179):698–699. doi: 10.1016/s0140-6736(61)91724-x. [DOI] [PubMed] [Google Scholar]
  10. HEYCK H., LAUDAHN G., LUDERS C. J. [Enzyme activity determinations in healthy human musculature and in myopathies. II. Enzyme activity changes in muscle in progressive muscular dystrophy]. Klin Wochenschr. 1963 May 15;41:500–509. doi: 10.1007/BF01490019. [DOI] [PubMed] [Google Scholar]
  11. HUGHES B. P. Serum enzymes in carriers of muscular dystrophy. Br Med J. 1962 Oct 13;2(5310):963–964. doi: 10.1136/bmj.2.5310.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. KARMEN A. A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum. J Clin Invest. 1955 Jan;34(1):131–133. [PubMed] [Google Scholar]
  13. KONTTINEN A. alpha-Hydroxybutyric dehydrogenase in the detection of myocardial infarction. Lancet. 1961 Sep 2;2(7201):556–556. doi: 10.1016/s0140-6736(61)92994-4. [DOI] [PubMed] [Google Scholar]
  14. LAURYSSENS M. G., LAURYSSENS M. J. ELECTROPHORETIC DISTRIBUTION PATTERN OF LACTATE DEHYDROGENASE IN MOUSE AND HUMAN MUSCULAR DYSTROPHY. Clin Chim Acta. 1964 Mar;9:276–284. doi: 10.1016/0009-8981(64)90108-1. [DOI] [PubMed] [Google Scholar]
  15. LEYBURN P., THOMSON W. H., WALTON J. N. An investigation of the carrier state in the Duchenne type muscular dystrophy. Ann Hum Genet. 1961 May;25:41–49. doi: 10.1111/j.1469-1809.1961.tb01495.x. [DOI] [PubMed] [Google Scholar]
  16. PEARSON C. M. Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase. N Engl J Med. 1957 Jun 6;256(23):1069–1075. doi: 10.1056/NEJM195706062562301. [DOI] [PubMed] [Google Scholar]
  17. PLUMMER D. T., ELLIOTT B. A., COOKE K. B., WILKINSON J. H. Organ specificity and lactate-dehydrogenase activity. 1. The relative activities with pyruvate and 2-oxobutyrate of electrophoretically separated fractions. Biochem J. 1963 May;87:416–422. doi: 10.1042/bj0870416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. RAYMOND S. A convenient apparatus for vertical gel electrophoresis. Clin Chem. 1962 Sep-Oct;8:455–470. [PubMed] [Google Scholar]
  19. RAYMOND S., WEINTRAUB L. Acrylamide gel as a supporting medium for zone electrophoresis. Science. 1959 Sep 18;130(3377):711–711. doi: 10.1126/science.130.3377.711. [DOI] [PubMed] [Google Scholar]
  20. RICHTERICH R., GAUTIER E., EGLI W., ZUPPINGER K., ROSSI E. [Progressive muscular dystrophy. I. The heterogenicity of serum lactic dehydrgenase]. Klin Wochenschr. 1961 Apr 1;39:346–352. doi: 10.1007/BF01492249. [DOI] [PubMed] [Google Scholar]
  21. ROSALKI S. B. SERUM ALPHA-HYDROXYBUTYRATE DEHYDROGENASE: A NEW TEST FOR MYOCARDIAL INFARCTION. Br Heart J. 1963 Nov;25:795–802. doi: 10.1136/hrt.25.6.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. SCHAPIRA G., DREYFUS J. C., SCHAPIRA F. L'élévation du taux de l'aldolase sérique; test biochimique des myopathies. Sem Hop. 1953 Jun 10;29(38):1917–1920. [PubMed] [Google Scholar]
  23. THOMPSON R. A., VIGNOS P. J., Jr Serum aldolase in muscle disease. AMA Arch Intern Med. 1959 Apr;103(4):551–564. doi: 10.1001/archinte.1959.00270040037004. [DOI] [PubMed] [Google Scholar]
  24. THOMSON W. H., LEYBURN P., WALTON J. N. Serum enzyme activity in muscular dystrophy. Br Med J. 1960 Oct 29;2(5208):1276–1281. doi: 10.1136/bmj.2.5208.1276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. VIGNOS P. J., Jr, LEFKOWITZ M. A biochemical study of certain skeletal muscle constituents in human progressive muscular dystrophy. J Clin Invest. 1959 Jun;38(6):873–881. doi: 10.1172/JCI103869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. WIEME R. J., HERPOL J. E. Origin of the lactate dehydrogenase isoenzyme pattern found in the serum of patients having primary muscular dystrophy. Nature. 1962 Apr 21;194:287–288. doi: 10.1038/194287b0. [DOI] [PubMed] [Google Scholar]
  27. WILSON K. M., EVANS K. A., CARTER C. O. CREATINE KINASE LEVELS IN WOMEN WHO CARRY GENES FOR THREE TYPES OF MUSCULAR DYSTROPHY. Br Med J. 1965 Mar 20;1(5437):750–753. doi: 10.1136/bmj.1.5437.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. WROBLEWSKI F., LADUE J. S. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med. 1955 Oct;90(1):210–213. doi: 10.3181/00379727-90-21985. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES